|
1. Kuo B, Urma D. Esophagus-anatomy and development. GI Motility. 2006 May Available from: https://www.nature.com/gimo/contents/pt1/full/gimo6.html doi:10.1038/gimo6 2. Ott DJ. Motility disorders of the esophagus. Radiol Clin North Am. 1994;32(6):1117-34. 3. Khan FM. Gibbons JP. Khan's the physics of radiation therapy: Lippincott Williams & Wilkins; 2014. 4. Bhide S, Newbold K, Harrington K, Nutting C. Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br J Radiol. 2012;85(1013):487-94. 5. Nair CK, Parida DK, Nomura T. Radioprotectors in radiotherapy. J Radiat Res. 2001;42(1):21-37. 6. Lederman M. The early history of radiotherapy:1895-1939. Int J of Radiat Oncol Biol Phys. 1981;7(5):639-48. 7. Dantigny R, Tanty A, Fourneret P, Genin N, Bayet-Papin B, Mousseau M, et al. Prevalence of pain in radiotherapy and improvement of its management. Bulletin du cancer. 2018;105(12):1183-92. 8. Hubenak JR, Zhang Q, Branch CD, Kronowitz SJ. Mechanisms of injury to normal tissue after radiotherapy: a review. Plast Reconstr Surg. 2014;133(1):49-56. 9. Attix FH. Introduction to radiological physics and radiation dosimetry: John Wiley & Sons; 2008. 10. Formenti SC, Demaria S. Systemic effects of local radiotherapy. Lancet Oncol. 2009;10(7):718-26. 11. Murro D, Jakate S. Radiation esophagitis. Arch Pathol Lab Med. 2015;139(6):827-30. 12. Hirota S, Tsujino K, Hishikawa Y, Watanabe H, Kono K, Soejima T, et al. Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol. 2001;58(3):273-8. 13. Yamashita H, Takenaka R, Omori M, Imae T, Okuma K, Ohtomo K, et al. Involved-field radiotherapy (IFRT) versus elective nodal irradiation(ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study. Radiation Oncology. 2015;10(1):1-10. 14. Wada K, Kishi N, Kanayama N, Hirata T, Ueda Y, Kawaguchi Y, et al. Predictors of acute radiation esophagitis in non-small cell lung cancer patients treated with accelerated hyperfractionated chemoradiotherapy. Anticancer research. 2019;39(1):491-7. 15. Bardley J, Movsas B. Radiation esophagitis: predictive factors and preventative strategies. Semin Radiat Oncol. 2004;14:280-6. 16. West K, Schneider M, Wright C, Collins RB, Coburn N, Tiver K, et al. Radiation-induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation. J Med Imaging Radiat Oncol. 2020;64(1):113-119. 17. Amer MH. Genetic factors and breast cancer laterality. Cancer management and research. 2014;6:191.
|
